Immunomodulation of Breast Cancer via Tumor Antigen Specific Th1
Mary L. Disis, Kyong Hwa Park
Cancer Res Treat. 2009;41(3):117-121.   Published online 2009 Sep 28     DOI: https://doi.org/10.4143/crt.2009.41.3.117
Citations to this article as recorded by Crossref logo
Immunomodulation with β-glucan from Pleurotus ostreatus in patients with endocrine-dependent breast cancer
Jan Spacek, Michal Vocka, Eva Zavadova, Bohuslav Konopasek, Lubos Petruzelka
Immunotherapy.2022; 14(1): 31.     CrossRef
COMPREHENSIVE REVIEW ON ETIOPATHOGENESIS, TREATMENT AND EMERGING THERAPIES OF BREAST CANCER
ARUN KUMAR
Asian Journal of Pharmaceutical and Clinical Research.2021; : 20.     CrossRef
A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers
Alexandre de Nonneville, Pascal Finetti, José Adelaide, Éric Lambaudie, Patrice Viens, Anthony Gonçalves, Daniel Birnbaum, Emilie Mamessier, François Bertucci
Cancers.2019; 11(8): 1158.     CrossRef
CCL2 conditionally determines CCL22-dependent Th2-accumulation during TGF-β-induced breast cancer progression
Palash Kumar Mandal, Subir Biswas, Gunjan Mandal, Suman Purohit, Arnab Gupta, Amita Majumdar (Giri), Sougata Roy Chowdhury, Arindam Bhattacharyya
Immunobiology.2018; 223(2): 151.     CrossRef
Breaking through to the Other Side: Microenvironment Contributions to DCIS Initiation and Progression
Andrew C. Nelson, Heather L. Machado, Kathryn L. Schwertfeger
Journal of Mammary Gland Biology and Neoplasia.2018; 23(4): 207.     CrossRef
The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer
François Bertucci, Pascal Finetti, Ines Simeone, Wouter Hendrickx, Ena Wang, Francesco M. Marincola, Patrice Viens, Emilie Mamessier, Michele Ceccarelli, Daniel Birnbaum, Davide Bedognetti
British Journal of Cancer.2018; 119(11): 1383.     CrossRef
Cognitive Behavioral Stress Management for Healthy Women at Risk for Breast Cancer: a Novel Application of a Proven Intervention
Bonnie A. McGregor, Emily D. Dolan, Karly M. Murphy, Timothy S. Sannes, Krista B. Highland, Denise L. Albano, Alison A. Ward, Anna M. Charbonneau, Mary W. Redman, Rachel M. Ceballos
Annals of Behavioral Medicine.2015; 49(6): 873.     CrossRef
Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells
Stefanie J. Mandl, Ryan B. Rountree, Katie Dalpozzo, Lisa Do, John R. Lombardo, Peter L. Schoonmaker, Ulrike Dirmeier, Robin Steigerwald, Thierry Giffon, Reiner Laus, Alain Delcayre
Cancer Immunology, Immunotherapy.2012; 61(1): 19.     CrossRef
Association of CD27 and CD70 gene polymorphisms with risk of sporadic breast cancer in Chinese women in Heilongjiang Province
Fengyan Xu, Dalin Li, Qiujin Zhang, Zhenkun Fu, Weiguang Yuan, Da Pang, Dianjun Li
Breast Cancer Research and Treatment.2012; 133(3): 1105.     CrossRef
Kinome expression profiling and prognosis of basal breast cancers
Renaud Sabatier, Pascal Finetti, Emilie Mamessier, Stéphane Raynaud, Nathalie Cervera, Eric Lambaudie, Jocelyne Jacquemier, Patrice Viens, Daniel Birnbaum, François Bertucci
Molecular Cancer.2011;[Epub]     CrossRef
Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance
Tetsuro Sasada, Shigetaka Suekane
Immunotherapy.2011; 3(10): 1235.     CrossRef
Bridging Innate and Adaptive Antitumor Immunity Targeting Glycans
Anastas Pashov, Bejatolah Monzavi-Karbassi, Gajendra P. S. Raghava, Thomas Kieber-Emmons
Journal of Biomedicine and Biotechnology.2010; 2010: 1.     CrossRef